To date, glioblastoma is not curable. Headed by Prof. Dr. Ghazaleh Tabababai, treatment of the first patient in an international Phase I clinical trial has started in Tübingen.
Read the press release of University Hospital Tübingen (in German)
Copyright: Verena Müller / UKT
